Coastal Pediatric Associates (CPA) has opened the Antibody Infusion Clinic for high risk, medically complex children and young adults ages 12 and older who test positive for COVID-19, but do not meet ...

As new COVID variants rise in the U.S., antibodies are getting wiped off the list of treatments. NPR's Pien Huang explains why these infusion treatments didn't last and how scientists are searching ...

On the same day North Carolina hospitals reported a record number of COVID-19 patients in intensive care units across the state, Gov. Roy Cooper signaled he will take action expanding access to a ...

Nov. 14—The first wave of Covid-19 peaked in the Flathead Valley exactly a year ago this week. Active cases in the county climbed to nearly 2,500 — the highest of the entire pandemic — and statewide ...

In a recent study posted to the medRxiv* preprint server, researchers comparatively evaluated antibody (Ab) responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among ...

The FDA has authorized a new treatment that may help immunocompromised people be protected from COVID-19. The treatment is a monoclonal antibody infusion that is expected to be available this April.

Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat ...

Sandoz’s Tyruko (natalizumab), the only FDA approved natalizumab biosimilar for adults with relapsing multiple sclerosis and Crohn’s disease, is now available by prescription in the United States ...

The finding provides further evidence that antibodies—specialized proteins that the body produces to fight infections—could one day be used as a method to prevent people from becoming infected with ...

Background. Ebola virus (EBOV) neutralizing antibody in plasma may reduce viral load following administration of plasma to patients with Ebola virus disease (EVD), but measurement of these antibodies ...